Please assess the completion status of the following clinical trial:

Trial Title: Analgesic Benefits of Genicular Nerve Blocks of the Posterior Knee for Patients Undergoing ACL Reconstruction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. patients who are presenting for ACL reconstruction~2. candidates for peripheral nerve blocks patients~3. ASA 1-3~Exclusion Criteria:~1. Patient refusal~2. ASA Classification of 4 or higher~3. Pre-existing neuropathy in the femoral or sciatic distribution~4. Coagulopathy~5. Infection at the site~6. Non-English speaking or non-reading patients~7. Chronic opioid use (\>3months)~8. Pregnancy~9. Any other contra-indication to regional anesthesia~10. Failed femoral nerve block~11. Sciatic nerve block placed due to severe pain not managed by intravenous and oral agents.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Study Drug (Type: ACTIVE_COMPARATOR): Ultrasound guided posterior genicular nerve infiltration with 30mL of Bupivicaine 0.20% with epinephrine 1:300,000 (Study Drug)
- Preservative free normal saline (Type: SHAM_COMPARATOR): Ultrasound guided posterior genicular nerve infiltration posterior knee with 30mL of preservative free normal saline

Based on this trial design, predict the completion outcome and termination type (if applicable).